We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$718B
AUM Growth
-$112B
Cap. Flow
+$11.7B
Cap. Flow %
1.63%
Top 10 Hldgs %
17.54%
Holding
7,270
New
568
Increased
2,561
Reduced
2,729
Closed
610

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.52%
3 Financials 10.5%
4 Consumer Discretionary 7.88%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABX
5926
Abacus Global Management
ABX
$834M
$4K ﹤0.01%
+448
New +$4.46K
ADN
5927
DELISTED
Advent Technologies
ADN
$4K ﹤0.01%
56
-566
-91% -$34.2K
BDTX icon
5928
Black Diamond Therapeutics
BDTX
$121M
$4K ﹤0.01%
1,512
-258,960
-99% -$602K
BNZIW
5929
DELISTED
Banzai International Warrant
BNZIW
0
BSCP
5930
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$4K ﹤0.01%
194
-17,928
-99% -$369K
BSJP
5931
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
$4K ﹤0.01%
169
-13,665
-99% -$314K
CADL icon
5932
Candel Therapeutics
CADL
$783M
$4K ﹤0.01%
1,247
-2,140
-63% -$8.57K
CRIS icon
5933
Curis
CRIS
$3.49M
$4K ﹤0.01%
10
-783
-99% -$327K
EVGN icon
5934
Evogene
EVGN
$9.67M
$4K ﹤0.01%
477
-515
-52% -$5.04K
GEOS icon
5935
Geospace Technologies
GEOS
$67.9M
$4K ﹤0.01%
866
-501
-37% -$2.86K
GGN
5936
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$837M
$4K ﹤0.01%
1,000
-200
-17% -$784
GMF icon
5937
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$440M
$4K ﹤0.01%
43
HBB icon
5938
Hamilton Beach Brands
HBB
$443M
$4K ﹤0.01%
322
-5,936
-95% -$62.7K
IMTB icon
5939
iShares Core 5-10 Year USD Bond ETF
IMTB
$275M
$4K ﹤0.01%
95
+9
+10% +$408
JMST icon
5940
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.15B
$4K ﹤0.01%
79
-29,471
-100% -$1.49M
JPXN
5941
iShares JPX-Nikkei 400 ETF
JPXN
$141M
$4K ﹤0.01%
75
LRMR icon
5942
Larimar Therapeutics
LRMR
$454M
$4K ﹤0.01%
2,004
-97
-5% -$287
LSF icon
5943
Laird Superfood
LSF
$46.8M
$4K ﹤0.01%
1,989
-2,777
-58% -$7.59K
LXP.PRC icon
5944
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$94.9M
$4K ﹤0.01%
78
MAXN
5945
CALL
DELISTED
Maxeon Solar Technologies
MAXN
$4K ﹤0.01%
3
SPSM icon
5946
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
$4K ﹤0.01%
119
+69
+138% +$2.68K
TNON icon
5947
Tenon Medical
TNON
$2.8M
$4K ﹤0.01%
+1
New +$29.1K
STLNW
5948
Starling Oncology, Inc. Warrant
STLNW
$5.31M
0
TXMD icon
5949
TherapeuticsMD
TXMD
$24.1M
$4K ﹤0.01%
336
-4,769
-93% -$45.5K
ZEPP
5950
Zepp Health
ZEPP
$79.9M
$4K ﹤0.01%
517
-391
-43% -$3.6K

Similar funds

JP Morgan Chase's Q2 2022 Portfolio in Review

As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
  • JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
  • JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
  • JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
  • JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.